The way I read this is that Allergan is making a lump sum payment, and then ongoing annual royalties beyond that. That makes sense to me, as the money is coming

The way I read this is that Allergan is making a lump sum payment, and then ongoing annual royalties beyond that. That makes sense to me, as the money is coming from the sales of Restasis at inflated/uncompetitive pricing.